Fluticasone Propionate Powder, Metered
Product Images NDC 66993-792
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 66993-792). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Fluticasone Propionate Diskus Spl Graphic 02)
This text appears to be a description of a study or experiment involving the use of Fluticasone Propionate DISKUS at a dosage of 100 mcg twice daily. The baseline forced expiratory volume (FEV) for the participants was 2.60 L. The text also mentions a placebo group with a baseline FEV of 2.62 L. The " % Change from Baseline in FEV" is mentioned as well. The text includes a chart or timeline with various timepoints labeled from 0 to 12. However, without additional context or information, it is difficult to provide a more detailed description of the content.*
Figure 2 (Fluticasone Propionate Diskus Spl Graphic 03)
The text appears to be a description of a medical evaluation involving the use of Fluticasone Propionate DISKUS at a dosage of 100 micrograms twice daily. The evaluation includes measuring FEV (Forced Expiratory Volume) at baseline, with a starting value of 2.26 L. There is also a mention of a placebo with a baseline FEV value of 2.35. The text indicates a percentage change from baseline but does not provide specific information about the change. The evaluation seems to have a time frame of 12 weeks, as indicated by the endpoints mentioned at 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 weeks.*
Figure 3 (Fluticasone Propionate Diskus Spl Graphic 04)
Figure 4 (Fluticasone Propionate Diskus Spl Graphic 05)
Figure A (Fluticasone Propionate Diskus Spl Graphic 06)
Figure B (Fluticasone Propionate Diskus Spl Graphic 07)
Figure C (Fluticasone Propionate Diskus Spl Graphic 08)
Figure D (Fluticasone Propionate Diskus Spl Graphic 09)
Figure E (Fluticasone Propionate Diskus Spl Graphic 10)
Figure F (Fluticasone Propionate Diskus Spl Graphic 11)
Figure G (Fluticasone Propionate Diskus Spl Graphic 12)
Figure H (Fluticasone Propionate Diskus Spl Graphic 13)
Fluticasone Propionate Diskus 50 Mcg 60 Dose Carton (Fluticasone Propionate Diskus Spl Graphic 14)
This text appears to be a description of a medication called Fluticasone Propionate Diskus, which is an inhalation powder used for oral inhalation. Each blister contains 50 micrograms of fluticasone propionate with lactose. The package includes 1 Diskus Inhalation Device containing 1 foil strip of 60 blisters. The text also mentions that the patient should refer to the enclosed Patient Information leaflet for instructions and dosage information.*
Fluticasone Propionate Diskus 100 Mcg 60 Dose Carton (Fluticasone Propionate Diskus Spl Graphic 15)
This is a description of a medication called Fluticasone Propionate Diskus Inhalation Powder. It is intended for oral inhalation only and each blister contains 100 mcg of fluticasone propionate with lactose. It is dispensed with an enclosed Patient Information leaflet and the dosage information can be found in the prescribing information. The package includes 1 Diskus Inhalation Device containing 1 Foil Strip of 60 Blisters.*
Fluticasone Propionate Diskus 250 Mcg 60 Dose Carton (Fluticasone Propionate Diskus Spl Graphic 16)
This text is a product description for a medication called "Fluticasone Propionate Diskus". It is an inhalation powder used for oral inhalation only. Each blister contains 250 mcg of fluticasone propionate with lactose. The product comes with a Diskus inhalation device that contains 1 foil strip of 60 blisters. The text also mentions an enclosed Patient Information leaflet and advises to refer to the prescribing information for dosage details.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.